| Literature DB >> 32923756 |
Xiang Gao1,2,3, Liping Zhang1,3, Peng Zhou1,3, Yongguang Zhang1,3, Yanming Wei2, Yonglu Wang1,3, Xinsheng Liu1,3.
Abstract
Porcine deltacoronavirus (PDCoV) is a newly emerging porcine pathogenic enteric coronavirus that can cause diarrhea, vomiting, dehydration, and a high mortality rate in piglets. At present, the understanding of PDCoV pathogenesis is very limited, which seriously hinders effective prevention and control. In this study, liquid chromatography tandem-mass spectrometry (LC-MS/MS) combined with tandem mass tag (TMT) labeling was performed to compare the differential expression of proteins in PDCoV-infected and mock-infected LLC-PK cells at 18 h post-infection (hpi). In addition, the parallel reaction monitoring (PRM) technique was used to verify the quantitative proteome data. A total of 4624 differentially expressed proteins (DEPs) were quantitated, of which 128 were significantly upregulated, and 147 were significantly downregulated. Bioinformatics analysis revealed that these DEPs were involved mainly in the defense response, apoptosis, and the immune system, and several DEPs may be related to interferon-stimulated genes and the immune system. Based on DEP bioinformatics analysis, we propose that PDCoV infection may utilize the apoptosis pathway of host cells to achieve maximum viral replication. Meanwhile, the host may be able to stimulate the transcription of interferon-stimulated genes (ISGs) through the JAK/STAT signaling pathway to resist the virus. Overall, in this study, we presented the first application of proteomics analysis to determine the protein profile of PDCoV-infected cells, which provides valuable information with respect to better understanding the host response to PDCoV infection and the specific pathogenesis of PDCoV infection.Entities:
Year: 2020 PMID: 32923756 PMCID: PMC7482077 DOI: 10.1021/acsomega.0c00886
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1PDCoV infection in LLC-PK cells. (A) Cytopathic effects (CPEs) of LLC-PK cells at 6, 12, 18, 24, and 30 h after PDCoV infection and mock-infected cells at 30 h as a negative control. (B) Infected LLC-PK cells were stained for immunofluorescence at 6, 12, 18, and 24 h after infection, and mock-infected cells at 36 h were used as a control. (C) One-step growth curve of the PDCoV strain CH/XJYN/2016 in LLC-PK cells.
Figure 2Subcellular location of the differentially expressed proteins in LLC-PK cells infected with PDCoV. (A) Upregulated protein subcellular localization in PDCoV-infected cells. (B) Downregulated protein subcellular localization in PDCoV-infected cells.
Figure 3Functional characterization of upregulated and downregulated proteins. (A) Biological process; (B) cellular component; (C) molecular function.
Figure 4Bioinformatic analysis of differentially expressed proteins. These differentially expressed proteins were subjected to (A) Gene Ontology-based enrichment analysis of biological processes and (B) KEGG pathway-based enrichment analysis. STRING software was used to construct an interaction diagram of the differentially expressed protein network to show the functional connection between differentially expressed proteins (C).
Analysis and Comparison of Quantitative Results of Nine Candidate Proteins TMT and PRM
| protein description | gene symbol | signature peptides | PD/N ratio TMT | PD/N ratio PRM | PRM |
|---|---|---|---|---|---|
| growth factor receptor-bound protein 2 | GRB2 | ESESAPGDFSLSVK | 1.27 | 1.23 | 2.5 × 10–3 |
| alpha-2-macroglobulin receptor-associated protein precursor | LRPAP1 | SEGLDEDGEKEYNILLETLSR | 0.81 | 0.76 | 4.7 × 10–2 |
| UDP-glucuronosyl transferase | UGT1A6 | YYTAFSDR | 0.80 | 0.74 | 2.2 × 10–2 |
| poly[ADP-ribose] polymerase | PARP1 | DSEEAETIRTTNFAGILSQGLR | 0.76 | 0.60 | 1.7 × 10–3 |
| histone H4 | ISGLIYEETRVFLENVIRDAVTYTEHAK | 0.56 | 0.31 | 5.7 × 10–6 | |
| DNA topoisomerase 2 | TOP2B | LLFPAVDDNLLKSQDFGNLFSFPSYSQK | 0.80 | 0.48 | 1.0 × 10–4 |
| histone cluster 1 H1 family member e | HIST1H1E | ASGPPVSELITKSGVSLAALK | 0.50 | 0.32 | 1.8 × 10–4 |
| promyelocytic leukemia | PML | QVVAHVLAQEQELLEGVNARASPEATSTPR | 1.38 | 1.26 | 5.7 × 10–2 |
| interferon-induced GTP-binding protein Mx2 | MX2 | GPENNLYSPFEEK | 2.18 | 19.29 | 9.7 × 10–5 |